Effects of glucosamine hydrochloride and chondroitin sulphate, alone and in combination, on normal and interleukin-1 conditioned equine articular cartilage explant metabolism.
- Journal Article
- Research Support
- Non-U.S. Gov't
Summary
The research article investigates the effects of glucosamine (GU) and chondroitin sulphate (CS), either singularly or in combination, on horse articular cartilage metabolism in normal conditions and under interleukin-1alpha condition (a state promoting inflammation). It suggests that higher doses and a combination of both GU and CS may assist in preventing or treating osteoarthritis (OA) without causing harm to cartilage metabolism, particularly through limiting the release and breakdown of glycosaminoglycans (GAG).
Objective and Methodology
The core objective of the study was to:
- Understand the effects and ascertain optimum dosages of GU and CS on normal and IL-1 conditioned equine articular cartilage metabolism.
- Establish if the treatments were not harmful to cartilage metabolism.
- Determine if higher dosages and combined application of GU and CS would exhibit greater beneficial effects than lower dosages or individual application.
To achieve this, articular cartilage explants, sourced from the femoral trochlea and condyles, were cultivated in both normal and IL-1 conditioned media. The treatment groups comprised various concentrations of GU and CS, administered alone or together. The submitted concentrations were 0, 12.5, 25, 125, and 250 microg/ml.
Results
- The testing found no harmful effects on cartilage metabolism with the use of GU, CS, or a combination of both.
- Higher dosages of combined GU and CS resulted in reduced total GAG release into the media, indicating less degradation.
Conclusions
From the study, the researchers inferred the potential of combined GU and CS to prevent cartilage GAG degradation. The conclusion entails that a combination of GU and CS might be more effective in preventing or treating OA than using either product individually. While the study provides valuable findings about possible OA treatment options in horses, it also suggests a need for further research to conclusively determine the effects.
Cite This Article
Publication
Researcher Affiliations
- Equine Orthopaedic Research Laboratory, Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado 80523, USA.
MeSH Terms
- Animals
- Cartilage, Articular / drug effects
- Cartilage, Articular / metabolism
- Chondroitin Sulfates / pharmacology
- Chondroitin Sulfates / therapeutic use
- Culture Media
- Dose-Response Relationship, Drug
- Drug Synergism
- Glucosamine / pharmacology
- Glucosamine / therapeutic use
- Glycosaminoglycans / metabolism
- Horse Diseases / drug therapy
- Horse Diseases / immunology
- Horses
- Interleukin-1 / pharmacology
- Interleukin-1 / physiology
- Osteoarthritis / drug therapy
- Osteoarthritis / immunology
- Osteoarthritis / veterinary
- Random Allocation
- Recombinant Proteins / pharmacology
- Tissue Culture Techniques / veterinary
- Treatment Outcome
Citations
This article has been cited 4 times.- Veronese N, Demurtas J, Smith L, Reginster JY, Bruyère O, Beaudart C, Honvo G, Maggi S. Glucosamine sulphate: an umbrella review of health outcomes.. Ther Adv Musculoskelet Dis 2020;12:1759720X20975927.
- van de Water E, Oosterlinck M, Dumoulin M, Korthagen NM, van Weeren PR, van den Broek J, Everts H, Pille F, van Doorn DA. The preventive effects of two nutraceuticals on experimentally induced acute synovitis.. Equine Vet J 2017 Jul;49(4):532-538.
- Bascoul-Colombo C, Garaiova I, Plummer SF, Harwood JL, Caterson B, Hughes CE. Glucosamine Hydrochloride but Not Chondroitin Sulfate Prevents Cartilage Degradation and Inflammation Induced by Interleukin-1α in Bovine Cartilage Explants.. Cartilage 2016 Jan;7(1):70-81.
- Toida T, Sakai S, Akiyama H, Linhardt RJ. Immunological activity of chondroitin sulfate.. Adv Pharmacol 2006;53:403-15.